These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 2782856)
21. Correlation between ratio of serum doxycycline concentration to MIC and rapid decline of antibody levels during treatment of Q fever endocarditis. Rolain JM; Boulos A; Mallet MN; Raoult D Antimicrob Agents Chemother; 2005 Jul; 49(7):2673-6. PubMed ID: 15980335 [TBL] [Abstract][Full Text] [Related]
22. Genetic variation in TLR10 is not associated with chronic Q fever, despite the inhibitory effect of TLR10 on Coxiella burnetii-induced cytokines in vitro. Ammerdorffer A; Stappers MH; Oosting M; Schoffelen T; Hagenaars JC; Bleeker-Rovers CP; Wegdam-Blans MC; Wever PC; Roest HJ; van de Vosse E; Netea MG; Sprong T; Joosten LA Cytokine; 2016 Jan; 77():196-202. PubMed ID: 26364993 [TBL] [Abstract][Full Text] [Related]
23. Phagolysosomes of Coxiella burnetii-infected cell lines maintain an acidic pH during persistent infection. Maurin M; Benoliel AM; Bongrand P; Raoult D Infect Immun; 1992 Dec; 60(12):5013-6. PubMed ID: 1452331 [TBL] [Abstract][Full Text] [Related]
24. Hydroxychloroquine susceptibility determination of Coxiella burnetii in human embryonic lung (HEL) fibroblast cells. Angelakis E; Khalil JB; Le Bideau M; Perreal C; La Scola B; Raoult D Int J Antimicrob Agents; 2017 Jul; 50(1):106-109. PubMed ID: 28478211 [TBL] [Abstract][Full Text] [Related]
25. Analysis of Coxiella burnetii isolates in cell culture and the expression of parasite-specific antigens on the host membrane surface. Roman MJ; Crissman HA; Samsonoff WA; Hechemy KE; Baca OG Acta Virol; 1991 Nov; 35(6):503-10. PubMed ID: 1687632 [TBL] [Abstract][Full Text] [Related]
26. Coxiella burnetii isolates originating from infected cattle induce a more pronounced proinflammatory cytokine response compared to isolates from infected goats and sheep. Ammerdorffer A; Kuley R; Dinkla A; Joosten LAB; Toman R; Roest HJ; Sprong T; Rebel JM Pathog Dis; 2017 Jun; 75(4):. PubMed ID: 28387835 [TBL] [Abstract][Full Text] [Related]
27. Host and Bacterial Factors Control Susceptibility of Drosophila melanogaster to Coxiella burnetii Infection. Bastos RG; Howard ZP; Hiroyasu A; Goodman AG Infect Immun; 2017 Jul; 85(7):. PubMed ID: 28438980 [No Abstract] [Full Text] [Related]
28. Susceptibility of intracellular Coxiella burnetii to antimicrobial peptides in mouse fibroblast cells. Unsworth NB; Dawson RM; Wade JD; Liu CQ Protein Pept Lett; 2014; 21(2):115-23. PubMed ID: 24364858 [TBL] [Abstract][Full Text] [Related]
29. Three-dimensional reconstruction of Coxiella burnetii-infected L929 cells by high-voltage electron microscopy. Hechemy KE; McKee M; Marko M; Samsonoff WA; Roman M; Baca O Infect Immun; 1993 Oct; 61(10):4485-8. PubMed ID: 8406840 [TBL] [Abstract][Full Text] [Related]
30. Virulence of pathogenic Coxiella burnetii strains after growth in the absence of host cells. Kersh GJ; Oliver LD; Self JS; Fitzpatrick KA; Massung RF Vector Borne Zoonotic Dis; 2011 Nov; 11(11):1433-8. PubMed ID: 21867419 [TBL] [Abstract][Full Text] [Related]
31. In vitro susceptibility of Coxiella burnetii to azithromycin, doxycycline, ciprofloxacin and a range of newer fluoroquinolones. Lever MS; Bewley KR; Dowsett B; Lloyd G Int J Antimicrob Agents; 2004 Aug; 24(2):194-6. PubMed ID: 15288324 [No Abstract] [Full Text] [Related]
32. Infection and Persistence of Zarza SM; Militello M; Gay L; Levasseur A; Lepidi H; Bechah Y; Mezouar S; Mege JL Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674725 [TBL] [Abstract][Full Text] [Related]
33. Coxiella burnetii blood cultures from acute and chronic Q-fever patients. Musso D; Raoult D J Clin Microbiol; 1995 Dec; 33(12):3129-32. PubMed ID: 8586687 [TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of an immunodominant 28-kilodalton Coxiella burnetii outer membrane protein specific to isolates associated with acute disease. Zhang G; To H; Russell KE; Hendrix LR; Yamaguchi T; Fukushi H; Hirai K; Samuel JE Infect Immun; 2005 Mar; 73(3):1561-7. PubMed ID: 15731054 [TBL] [Abstract][Full Text] [Related]
35. In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin. Maurin M; Raoult D Antimicrob Agents Chemother; 1993 Dec; 37(12):2633-7. PubMed ID: 8109928 [TBL] [Abstract][Full Text] [Related]
36. Bacteriostatic and bactericidal activity of levofloxacin against Rickettsia rickettsii, Rickettsia conorii, 'Israeli spotted fever group rickettsia' and Coxiella burnetii. Maurin M; Raoult D J Antimicrob Chemother; 1997 Jun; 39(6):725-30. PubMed ID: 9222041 [TBL] [Abstract][Full Text] [Related]
37. Preliminary assessment of genome differences between the reference Nine Mile isolate and two human endocarditis isolates of Coxiella burnetii. Beare PA; Porcella SF; Seshadri R; Samuel JE; Heinzen RA Ann N Y Acad Sci; 2005 Dec; 1063():64-7. PubMed ID: 16481490 [TBL] [Abstract][Full Text] [Related]
38. The Effect of pH on Antibiotic Efficacy against Coxiella burnetii in Axenic Media. Smith CB; Evavold C; Kersh GJ Sci Rep; 2019 Dec; 9(1):18132. PubMed ID: 31792307 [TBL] [Abstract][Full Text] [Related]
39. Comparative virulence of intra- and interstrain lipopolysaccharide variants of Coxiella burnetii in the guinea pig model. Moos A; Hackstadt T Infect Immun; 1987 May; 55(5):1144-50. PubMed ID: 3570458 [TBL] [Abstract][Full Text] [Related]